Company intelligence / Profile preview

BIOLOG Life Science Institute

Bremen, Bremen, Germanybiolog.de ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

BIOLOG Life Science Institute supplies specialized research reagents and tools for signal transduction research, focusing on nucleotide analogs and modulators with broad adoption in academic and drug discovery research. Products have been cited in numerous publications and are widely used, but the company is not developing therapeutic drug candidates.

Modalities: Small moleculeNucleotide analogCyclic nucleotide modulator
Industry: Chemicals & Materials

Beyond the preview

Go deeper on BIOLOG Life Science Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOLOG Life Science Institute.

Explore the full profile